Literature DB >> 32008406

iAMPlified gene expression offers new insights in B cell precursor leukemia subtype.

Panagiotis Ntziachristos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32008406      PMCID： PMC7028508          DOI： 10.1080/10428194.2019.1695055

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  21 in total

1.  Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup.

Authors:  J Soulier; L Trakhtenbrot; V Najfeld; J M Lipton; S Mathew; H Avet-Loiseau; M De Braekeleer; S Salem; A Baruchel; S C Raimondi; S D Raynaud
Journal:  Leukemia       Date:  2003-08       Impact factor: 11.528

Review 2.  Acute Lymphoblastic Leukemia in Children.

Authors:  Stephen P Hunger; Charles G Mullighan
Journal:  N Engl J Med       Date:  2015-10-15       Impact factor: 91.245

3.  Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia.

Authors:  Ingegerd Ivanov Öfverholm; Anh Nhi Tran; Linda Olsson; Vasilios Zachariadis; Mats Heyman; Eva Rudd; Elisabeth Syk Lundberg; Magnus Nordenskjöld; Bertil Johansson; Ann Nordgren; Gisela Barbany
Journal:  Leuk Lymphoma       Date:  2016-04-19

4.  Dynamic regulation of p53 subnuclear localization and senescence by MORC3.

Authors:  Keiko Takahashi; Naofumi Yoshida; Naoko Murakami; Kiyo Kawata; Hiroyuki Ishizaki; Miki Tanaka-Okamoto; Jun Miyoshi; Andrew R Zinn; Hiroaki Shime; Norimitsu Inoue
Journal:  Mol Biol Cell       Date:  2007-03-01       Impact factor: 4.138

Review 5.  Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.

Authors:  Sandeep Gurbuxani; Paresh Vyas; John D Crispino
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

6.  Chromatin assembly factor-1, a marker of clinical value to distinguish quiescent from proliferating cells.

Authors:  Sophie E Polo; Stamatios E Theocharis; Jerzy Klijanienko; Alexia Savignoni; Bernard Asselain; Philippe Vielh; Geneviève Almouzni
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

7.  Domains of genome-wide gene expression dysregulation in Down's syndrome.

Authors:  Audrey Letourneau; Federico A Santoni; Ximena Bonilla; M Reza Sailani; David Gonzalez; Jop Kind; Claire Chevalier; Robert Thurman; Richard S Sandstrom; Youssef Hibaoui; Marco Garieri; Konstantin Popadin; Emilie Falconnet; Maryline Gagnebin; Corinne Gehrig; Anne Vannier; Michel Guipponi; Laurent Farinelli; Daniel Robyr; Eugenia Migliavacca; Christelle Borel; Samuel Deutsch; Anis Feki; John A Stamatoyannopoulos; Yann Herault; Bas van Steensel; Roderic Guigo; Stylianos E Antonarakis
Journal:  Nature       Date:  2014-04-17       Impact factor: 49.962

8.  SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.

Authors:  L B Baughn; M M Meredith; L Oseth; T A Smolarek; B Hirsch
Journal:  Cancer Genet       Date:  2018-06-08

9.  The role of the RAS pathway in iAMP21-ALL.

Authors:  S L Ryan; E Matheson; V Grossmann; P Sinclair; M Bashton; C Schwab; W Towers; M Partington; A Elliott; L Minto; S Richardson; T Rahman; B Keavney; R Skinner; N Bown; T Haferlach; P Vandenberghe; C Haferlach; M Santibanez-Koref; A V Moorman; A Kohlmann; J A E Irving; C J Harrison
Journal:  Leukemia       Date:  2016-04-22       Impact factor: 11.528

Review 10.  RNA splicing factors as oncoproteins and tumour suppressors.

Authors:  Heidi Dvinge; Eunhee Kim; Omar Abdel-Wahab; Robert K Bradley
Journal:  Nat Rev Cancer       Date:  2016-06-10       Impact factor: 60.716
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.